These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 33909703)

  • 21. Characterization of mouse melanoma cell lines by their mortal malignancy using an experimental metastatic model.
    Nakamura K; Yoshikawa N; Yamaguchi Y; Kagota S; Shinozuka K; Kunitomo M
    Life Sci; 2002 Jan; 70(7):791-8. PubMed ID: 11833741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correction: Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms.
    Ilie M; Khambata-Ford S; Copie-Bergman C; Huang L; Juco J; Hofman V; Hofman P
    PLoS One; 2017; 12(10):e0186537. PubMed ID: 29028832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
    Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
    J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition by tyroserleutide (YSL) on the invasion and adhesion of the mouse melanoma cell.
    Yao Z; Che XC; Lu R; Zheng MN; Zhu ZF; Li JP; Jian X; Shi LX; Liu JY; Gao WY
    Mol Med; 2007; 13(1-2):14-21. PubMed ID: 17515953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of melanocortin 1 receptor slows melanoma growth, reduces tumor heterogeneity and increases survival.
    Kansal RG; McCravy MS; Basham JH; Earl JA; McMurray SL; Starner CJ; Whitt MA; Albritton LM
    Oncotarget; 2016 May; 7(18):26331-45. PubMed ID: 27028866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aerosol delivery of PEI-p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis.
    Gautam A; Densmore CL; Melton S; Golunski E; Waldrep JC
    Cancer Gene Ther; 2002 Jan; 9(1):28-36. PubMed ID: 11916242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effects of
    Brunetti RL; Da Paz DPA; Da Fonseca IIM; Nagamine MK; Mori CMC; Del Grande MP; Queiroz-Hazarbassanov N; Salles-Gomes COM; Dagli MLZ; Hernandez-Blazquez FJ
    Mol Clin Oncol; 2019 Nov; 11(5):511-516. PubMed ID: 31620282
    [No Abstract]   [Full Text] [Related]  

  • 28. The influence of neuropilin-1 silencing on semaphorin 3A and 3C activity in B16(F10) murine melanoma cells.
    Mazurek AM; Olbryt M
    Neoplasma; 2012; 59(1):43-51. PubMed ID: 22082309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of growth and pulmonary metastasis of B16-F10 murine melanoma by N-1554, a polyprenyl phosphate.
    Okamoto Y; Ohwaki T; Kawase S; Ishii Y; Hongyo T; Tahara Y; Mishima Y
    Cancer Lett; 1991 May; 57(2):159-63. PubMed ID: 2025888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
    LeGrue SJ; Hearn DR
    Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Cao C; Su Y; Gao Y; Luo C; Yin L; Zhao Y; Chen H; Xu A
    Evid Based Complement Alternat Med; 2018; 2018():4969028. PubMed ID: 30046339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combinatorial antitumor effects of indoleamine 2,3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model.
    Meng X; Du G; Ye L; Sun S; Liu Q; Wang H; Wang W; Wu Z; Tian J
    Int J Immunopathol Pharmacol; 2017 Sep; 30(3):215-226. PubMed ID: 28604143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An engineered PD-1-based and MMP-2/9-oriented fusion protein exerts potent antitumor effects against melanoma.
    Wei M; Liu X; Cao C; Yang J; Lv Y; Huang J; Wang Y; Qin Y
    BMB Rep; 2018 Nov; 51(11):572-577. PubMed ID: 30021673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production and characterization of tumor infiltrating lymphocyte clones derived from B16-F10 murine melanoma.
    Maeda K; Lafreniere R; Jerry LM
    J Invest Dermatol; 1991 Aug; 97(2):183-9. PubMed ID: 2071934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correction: Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.
    Makrakis D; Rounis K; Tsigkas AP; Georgiou A; Galanakis N; Tsakonas G; Ekman S; Papadaki C; Monastirioti A; Kontogianni M; Gioulbasanis I; Mavroudis I; Agelaki S
    PLoS One; 2023; 18(11):e0294384. PubMed ID: 37943779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.
    Humphries MJ; Yamada KM; Olden K
    J Clin Invest; 1988 Mar; 81(3):782-90. PubMed ID: 3343338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antimetastatic action of polyactin A and its mechanism].
    Qiang WA; Liu JR; Wang YS; Lei YD
    Yao Xue Xue Bao; 1994; 29(5):340-5. PubMed ID: 7976351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A lectin from Bothrops leucurus snake venom raises cytosolic calcium levels and promotes B16-F10 melanoma necrotic cell death via mitochondrial permeability transition.
    Aranda-Souza MA; Rossato FA; Costa RA; Figueira TR; Castilho RF; Guarniere MC; Nunes ES; Coelho LC; Correia MT; Vercesi AE
    Toxicon; 2014 May; 82():97-103. PubMed ID: 24593964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth and metastasis of B16-F10 melanoma cells is not critically dependent on host CD73 expression in mice.
    Burghoff S; Gong X; Viethen C; Jacoby C; Flögel U; Bongardt S; Schorr A; Hippe A; Homey B; Schrader J
    BMC Cancer; 2014 Dec; 14():898. PubMed ID: 25465225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment.
    Tsukamoto H; Fujieda K; Miyashita A; Fukushima S; Ikeda T; Kubo Y; Senju S; Ihn H; Nishimura Y; Oshiumi H
    Cancer Res; 2018 Sep; 78(17):5011-5022. PubMed ID: 29967259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.